OptimizeRx Sets Second Quarter Fiscal 2022 Conference Call for Tuesday, August 9 at 4:30 p.m. ET
21 juil. 2022 07h30 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., July 21, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Brings Real-World Evidence-Driven Engagement Programs to Social Media With New Exclusive Partnership
23 juin 2022 07h30 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., June 23, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Completes Platform Integration of TelaRep™ One-Click Prescriber Connectivity Solution
07 juin 2022 08h00 HE
|
OptimizeRx Corporation
- Launched in April 2020, TelaRep allows doctors to text pharmaceutical representatives directly from within the electronic health record (EHR) platform - As part of OptimizeRx’s Therapy, Initiation...
OptimizeRx to Participate in Upcoming June Conferences
24 mai 2022 08h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., May 24, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx’s Mike Rousselle Named One of 2022 PM360 ELITE 100
17 mai 2022 10h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Authorizes $20 Million Share Repurchase Program
17 mai 2022 08h30 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx to Participate in Upcoming May Conferences
10 mai 2022 08h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., May 10, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Reports First Quarter 2022 Financial Results, Revenue Up 22%, Successfully Completes EvinceMed Acquisition
04 mai 2022 16h01 HE
|
OptimizeRx Corporation
Revenue Up 22% to $13.7 million on increased average revenue per top 20 pharmaceutical manufacturer clientTraction with top 20 pharmaceutical manufacturers continues to advance and drive growthCash...
OptimizeRx Releases First Environmental, Social and Governance (ESG) Report
29 avr. 2022 08h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., April 29, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Sets First Quarter Fiscal 2022 Conference Call for Wednesday, May 4 at 4:30 p.m. ET
21 avr. 2022 08h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., April 21, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...